Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $342,475 | $634,815 | $97,989 | $369,947 |
| - Cash | $139,480 | $68,539 | $23,702 | $287,250 |
| + Debt | $1,429 | $2,417 | $2,565 | $3,289 |
| Enterprise Value | $204,424 | $568,693 | $76,852 | $85,986 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$141,865 | -$104,584 | -$106,631 | -$71,328 |
| % Margin | – | – | – | – |
| Net Income | -$129,474 | -$96,655 | -$104,787 | -$71,096 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.2 | -2.14 | -2.62 | -1.79 |
| % Growth | -2.8% | 18.3% | -46.4% | – |
| Operating Cash Flow | -$104,351 | -$83,727 | -$82,065 | -$50,690 |
| Capital Expenditures | -$159 | $0 | -$363 | -$1,575 |
| Free Cash Flow | -$104,510 | -$83,727 | -$82,428 | -$52,265 |